These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34140711)

  • 21. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives of older people with uncontrolled type 2 diabetes mellitus towards medication adherence: A qualitative study.
    Upamali S; Rathnayake S
    PLoS One; 2023; 18(8):e0289834. PubMed ID: 37561681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosocial aspects and contributions of behavioural science to medication-taking for adults with type 2 diabetes.
    Winkley K; Upsher R; Polonsky WH; Holmes-Truscott E
    Diabet Med; 2020 Mar; 37(3):427-435. PubMed ID: 31837158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicine-taking experiences and associated factors: comparison between Arabic-speaking and Caucasian English-speaking patients with Type 2 diabetes.
    Alzubaidi H; Mc Mamara K; Chapman C; Stevenson V; Marriott J
    Diabet Med; 2015 Dec; 32(12):1625-33. PubMed ID: 25761373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of metformin monotherapy discontinuation and reinitiation in people with type 2 diabetes mellitus in New Zealand.
    Horsburgh S; Sharples K; Barson D; Zeng J; Parkin L
    PLoS One; 2021; 16(4):e0250289. PubMed ID: 33882106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A risk-benefit assessment of metformin in type 2 diabetes mellitus.
    Howlett HC; Bailey CJ
    Drug Saf; 1999 Jun; 20(6):489-503. PubMed ID: 10392666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study.
    Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
    Ann Pharmacother; 2018 Apr; 52(4):305-313. PubMed ID: 29144162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of primary adherence to medications in patients with chronic conditions: A retrospective cohort study].
    Peper FE; Esteban S; Terrasa SA
    Aten Primaria; 2018 Feb; 50(2):96-105. PubMed ID: 28521859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial.
    Hulst AH; Polderman JAW; Ouweneel E; Pijl AJ; Hollmann MW; DeVries JH; Preckel B; Hermanides J
    Diabetes Obes Metab; 2018 Mar; 20(3):749-752. PubMed ID: 28940961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dispensing patterns for antidiabetic agents in New Zealand: are the guidelines being followed?
    Murray P; Norris H; Metcalfe S; Betty B; Young V; Locke B
    N Z Med J; 2017 Nov; 130(1465):12-18. PubMed ID: 29121620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study.
    Naffaa ME; Rosenberg V; Watad A; Tiosano S; Yavne Y; Chodick G; Amital H; Shalev V
    Scand J Rheumatol; 2020 May; 49(3):173-180. PubMed ID: 32208872
    [No Abstract]   [Full Text] [Related]  

  • 33. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
    Shearer AT; Bagust A; Ampudia-Blasco FJ; Martínez-Lage Alvarez B; Pérez Escolano I; París G
    Pharmacoeconomics; 2006; 24 Suppl 1():49-59. PubMed ID: 16800162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
    Ali M; Grogan S; Powell S; Staniford L; Nazir J; Landeira M; Covernton PJO; Jaggi A; Fatoye F; Holt M
    Adv Ther; 2019 Nov; 36(11):3110-3122. PubMed ID: 31559603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme.
    Khunti K; Gomes MB; Kosiborod M; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Tang F; Ji L;
    BMJ Open; 2020 Aug; 10(8):e034613. PubMed ID: 32868349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of health literacy with illness perceptions, medication beliefs, and medication adherence among individuals with type 2 diabetes.
    Shiyanbola OO; Unni E; Huang YM; Lanier C
    Res Social Adm Pharm; 2018 Sep; 14(9):824-830. PubMed ID: 29317189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
    Hansen RA; Farley JF; Droege M; Maciejewski ML
    Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Adherence in Type 2 Diabetes.
    Swe K; Reddy SSK
    Clin Geriatr Med; 2020 Aug; 36(3):477-489. PubMed ID: 32586476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.